Translational models and tools to reduce clinical trials and improve regulatory decision making for QTc and proarrhythmia risk (ICH E14/S7B updates)

DG Strauss, WW Wu, Z Li, J Koerner… - Clinical Pharmacology …, 2021 - Wiley Online Library
After multiple drugs were removed from the market secondary to drug‐induced torsade de
pointes (TdP) risk, the International Council for Harmonisation (ICH) released guidelines in …

Endogenous opiates and behavior: 2022

RJ Bodnar - Peptides, 2023 - Elsevier
This paper is the forty-fifth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder

L Wang, ND Volkow, NA Berger… - Journal of Clinical …, 2023 - Wiley Online Library
Abstract Importance More than 109,000 Americans died of drug overdose in 2022, with
81,231 overdose deaths involving opioids. Methadone, buprenorphine and naltrexone are …

Current and future therapeutic options in pain management: Multi-mechanistic opioids involving both MOR and NOP receptor activation

F Coluzzi, L Rullo, MS Scerpa, LM Losapio, M Rocco… - CNS drugs, 2022 - Springer
Opioids are widely used in chronic pain management, despite major concerns about their
risk of adverse events, particularly abuse, misuse, and respiratory depression from …

Discovery and characterization of multiple classes of human CatSper blockers

EJ Carlson, R Francis, Y Liu, P Li, M Lyon… - …, 2022 - Wiley Online Library
The cation channel of sperm (CatSper) is a validated target for nonhormonal male
contraception, but it lacks selective blockers, hindering studies to establish its role in both …

Long-acting buprenorphine formulations as a new strategy for the treatment of opioid use disorder

I Maremmani, M Dematteis, EJ Gorzelanczyk… - Journal of Clinical …, 2023 - mdpi.com
Long-acting buprenorphine formulations have been recently marketed for the Opioid Agonist
Treatment (OAT) of opioid use disorder (OUD) associated with medical, social, and …

Antipsychotic polypharmacy-related cardiovascular morbidity and mortality: a comprehensive review

AN Edinoff, ED Ellis, LM Nussdorf, TW Hill… - Neurology …, 2022 - mdpi.com
Schizophrenia is a psychotic disorder that exists at the more extreme end of a spectrum of
diseases, and significantly affects daily functioning. Cardiovascular adverse effects of …

Top ten tips palliative care clinicians should know about buprenorphine

KJ Neale, MB Weimer, MP Davis, KF Jones… - Journal of palliative …, 2023 - liebertpub.com
Pain management in palliative care (PC) is becoming more complex as patients survive
longer with life-limiting illnesses and population-wide trends involving opioid misuse …

Transdermal buprenorphine for acute pain in the clinical setting: a narrative review

JV Pergolizzi Jr, P Magnusson, JA LeQuang… - Journal of pain …, 2021 - Taylor & Francis
Transdermal buprenorphine is indicated for chronic pain management, but as its role in the
clinical management of acute pain is less clear, this narrative review examines studies of the …

Buprenorphine-related deaths in North Carolina from 2010 to 2018

SC Bishop-Freeman, LW Friederich… - Journal of Analytical …, 2021 - academic.oup.com
Buprenorphine (BUP) is a commonly prescribed medication for the treatment of opioid use
disorder (OUD). As prescriptions increase in North Carolina, BUP is more frequently …